ALA 7.69% 18.0¢ arovella therapeutics limited

meeting report, page-3

  1. 2,755 Posts.
    lightbulb Created with Sketch. 476
    Great post Clyde,
    I remain positive however my concern is if Novadel is such a good deal, how has the company become so distressed and how is Suda going to manage the administration of products with a somewhat limited ability to generate/raise cash.

    I can only assume it to be costly to maintain if they have burnt through $100mil.

    Suda needs a trade sale soon for its own and Novadels future existence.

    Cash is the key to the whole thing and although we have access to 7mil, it's not our money and we're having to sell the farm monthly to use it.

    Was there any genuine indication given that there is interested parties looking to purchase the Artimist project??

    Cheers



 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.